Scandinavian Medical Solutions is expected to publish its half-year report for the 2025/26 financial year on 19 May 2026.
The upcoming half-year report from Scandinavian Medical Solutions covers the first six months of a financial year that has seen mixed developments, with both new orders and lowered expectations for the full financial year.
Scandinavian Medical Solutions began the financial year with several announced sales of used diagnostic imaging equipment. In autumn 2025, SMS announced four orders across the US market and Eastern Europe. In December, this was followed by the sale of a used PET/CT scanner to a customer in the US, and in January 2026 a PET/MR scanner was sold to an Eastern European buyer for DKK 3.5-5 million.
In April, however, the company lowered its guidance for the full financial year. SMS now expects revenue in the range of DKK 190-220 million, compared with the previous DKK 220-250 million, while EBITDA has been reduced from DKK 11-15 million to DKK 0-5 million. The reasons for the downgrade were increased global uncertainty, including trade barriers in the US, geopolitical tensions in the Middle East and rising oil prices, which have led several of the company's customers to postpone investments.
The upcoming half-year financial statements will therefore be the first consolidated measure of how these challenges are affecting the company's financial performance. It will also be interesting to gain better insight into what the company's management expects from the second half of the financial year. The report on 19 May is therefore expected to provide an updated picture of how robust the core business is under the current market conditions.